Analyzing Madrigal Pharmaceuticals' potential in the competitive NASH drug market and why it may be right for your portfolio.
Kroger Health, the arm of grocer Kroger that runs pharmacies and clinics across the U.S., said on Friday it had revamped its ...
Talking about weight and weight loss with Johann Hari, an Ozempic user and the author of "Magic Pill: The Extraordinary ...
About one-third of U.S. employer health plans are offering coverage of GLP-1 drugs for both diabetes management and weight ...
For the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes, have struggled to fill ...
Blue Cross Blue Shield of Michigan intends to drop coverage of GLP-1 obesity drugs for certain plans due to concerns about their cost, safety and efficacy, according to Bloomberg. The health ...
Boehringer Ingelheim today announced breakthrough results from a survodutide Phase II trial sub-analysis that demonstrate up to 64.5% of adults with fibrosis stages F2 and F3 (moderate to advanced ...
ALAMEDA, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative, biopharmaceutical company developing novel ...
(MENAFN- The Conversation) Obesity levels for adults have hit 26% in Britain and 42.5% in the United States, journalist Johann Hari writes in his new book, Magic Pill . In Australia, recent data shows ...
Obesity-Diabetes Drugs MarketAs per Future Market Insights’ latest industry analysis, the global obesity-diabetes drugs market was valued at around USD 54,452.0 million in 2023 and is anticipated to ...
About 4% of US Adults Age 65 and Older Have a Dementia Diagnosis, Survey Finds By Christy Santhosh (Reuters) - Some 4% of U.S. adults aged 65 and older say they have been diagnosed with dementia ...